Hydrocolloid Based Orodispersible Strip of BCS II Drug via 3D Printing – An Outline

Recent studies and new discoveries on hydrocolloid based Orodispersible strips (ODSs) are consolidated in the present review. produced through 3D printing, and particular focus on the formulation strategies of BCS IIdrugs was put. The 3D (3 dimensional) printing technologies, characterization, and the projections in the future. ODS have emerged as a patient-centric dosage form, particularly suited for paediatric, geriatric, and dysphagic populations. Hydrocolloids, owing to their excellent film-forming, fast disintegration, and biocompatibility properties, widely used as polymeric bases for ODS. As 3D printing has gained attention as an advanced manufacturing method and emerged as a flexible platform for manufacturing orodispersible strips (ODSs) which enables precise dose personalization, innovative multilayer structures, and novel release profiles. The integration of hydrocolloids polymers (natural and semi-synthetic) based ODs formulations marks a significant breakthrough due to its hydrophilicity, biocompatibility and rapid disintegration, thus enhancing the efficiency of BCS IIdrugs delivery and broadening the scope for such drugs biddable to this route.